GlassScriptPhysician profile
Samuel P Pollak
NPI 1225008089
$1,244.46
in general payments reported to CMS, 2019-2025
17 companies · $329 in 2025
The $329 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.62 · 2021: $74.77 · 2022: $225 · 2023: $304 · 2024: $254 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $887.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $263.73 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Coopervision INC. | $256.42 | 2019-2025 | Myday Contact Lens |
| Sun Pharmaceutical Industries INC. | $137.16 | 2019-2025 | Cequa |
| Alcon Vision LLC | $133.71 | 2022-2025 | Tryptyr, Rocklatan, Dailies Total1 |
| Oyster Point Pharma, INC. | $99.50 | 2022-2025 | Tyrvaya, Ryzumvi |
| Tarsus Pharmaceuticals, INC. | $99.06 | 2024 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $52.25 | 2023 | Acuvue |
| Abbvie INC. | $29.25 | 2024 | |
| Amgen INC. | $26.98 | 2024 | Tepezza |
| Rxsight INC | $23.16 | 2022 | |
| Aerie Pharmaceuticals, INC. | $23.06 | 2021 | |
| Horizon Therapeutics Plc | $22.89 | 2023 | Tepezza |
| Biotissue Holdings INC. | $20.96 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $16.03 | 2021 | |
| Kala Pharmaceuticals, INC. | $14.72 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $12.87 | 2023 | |
| Allergan, INC. | $12.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Pollak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.